The Actinic Keratosis Treatment Market is anticipated to reach USD 3.99 Billion by 2032 at 6.2% CAGR during the forecast period 2023-2032. Actinic keratosis (AK) is a common skin condition characterized by rough, scaly patches or lesions caused by sun exposure. While often benign, untreated AK can progress to squamous cell carcinoma, a type of skin cancer. As awareness of the risks associated...